ESC Premium Access

Tecarfarin pharmacokinetics and pharmacodynamics-A novel CYP2C9 independent vitamin K antagonist

Congress Presentation

About the speaker

Doctor Mark Midei

Armetheon, Monkton (United States of America)
0 follower

5 more presentations in this session

Familial clustering of venous thromboembolism - A Danish nationwide cohort study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)


Inhibitory effects of ticagrelor monotherapy on arachidonic acid induced platelet aggregation in patients with coronary heart disease

Speaker: Doctor J. Jiang (Beijing, CN)


Contemporary registry of intermediate and high risk pulmonary embolism patients presenting to a large tertiary medical center

Speaker: Doctor R. Beigel (Ramat Gan, IL)


Markers of thrombin generation in patients with ST-elevation myocardial infarction are associated with long term clinical outcome

Speaker: Mrs C. Hansen (Oslo, NO)


Presence of bacterial DNA in thrombus aspirates of patients with myocardial infarction.

Speaker: Doctor P. Pinon (Pontevedra, ES)


Access the full session

Insights on thrombosis and anticoagulants

Speakers: Doctor M. Midei, Ms C. Sindet-Pedersen, Doctor J. Jiang, Doctor R. Beigel, Mrs C. Hansen...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb